SeqOne is excited to attend the International Consortium on Newborn Sequencing, joining global leaders across healthcare, research, and policy at Harvard Medical School to advance genomic newborn screening. 

Key Themes:

  • Clinical Implementation & Data Reuse: Developing scalable frameworks for integrating genomic screening into routine newborn care and optimizing long-term data utilization.
  • Gene Selection & Curation: Modernizing screening criteria to define standardized, evidence-based gene lists for actionable childhood conditions.
  • Interoperability & Data Sharing: Establishing secure guidelines and shared ontologies for global genomic data exchange and research collaboration.

‍

📣 Join our Poster Presentation:

Industrializing National Genomic Newborn Screening: An Interpretation-Software Framework for Population-Scale Filtering, Automated Negative Triage, Knowledge Capitalization and IVDR-Compliant Reporting

Deploying genomic newborn screening at a national scale shifts the primary bottleneck from sequencing data generation to rapid, accurate variant interpretation. 

Developed in collaboration with France's Dijon-coordinated Perigenomed consortium, this session showcases a quality-managed, fully traceable platform built to streamline high-throughput screening. 

Learn how automated triage, inheritance-aware filtering, and deterministic reporting consistently handle the majority of negative cases, allowing expert clinical teams to focus their time on complex, ambiguous findings for predictable turnaround times.

Speaker: Jérôme Audoux, VP Product Innovation, Preventive Stream

Full schedule and details coming soon.

‍

🧬 In Boston for ICoNS? Let’s grab time.

Meet with the SeqOne team while we’re in Boston! We’re booking 1-on-1 sessions to discuss whatever is top of mind for your team, from scientific collaborations and business inquiries to live walkthroughs of our NGS platform.

  • One NGS Platform, Built for Scale: End-to-end interpretation workflow with broad wet lab and sequencer compatibility.
  • AI Precision for Clinical Workflows: Built for real-world labs, SeqOne delivers fast, actionable insights, helping your team spend less time on variant interpretation and more time on confident clinical decisions.
  • Evaluate SeqOne for yourself: Book a 1-on-1 session in Boston to explore our latest resources and learn how to start a free 30-day trial using your own data.

‍

Michael Vishnevetsky
VP Business Development, North America
👉Book a Meeting

‍

Jérôme Audoux
VP Product Innovation
👉Book a Meeting

‍